Cargando…
Long-term use of fluoxetine accelerates bone loss through the disruption of sphingolipids metabolism in bone marrow adipose tissue
Fluoxetine is a commonly prescribed antidepressant, and the mechanisms of increased bone fragility with its long-term use remain largely unknown. Here, we show that long-term administration of fluoxetine induces the disruption of sphingolipids metabolism in bone marrow adipose tissue (BMAT)through t...
Autores principales: | Zhang, Huili, Li, Kefeng, Zhao, Yanna, Zhang, Yilan, Sun, Jiawen, Li, Shihong, Lin, Guangwu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7217841/ https://www.ncbi.nlm.nih.gov/pubmed/32398744 http://dx.doi.org/10.1038/s41398-020-0819-5 |
Ejemplares similares
-
CCL3 in the bone marrow microenvironment causes bone loss and bone marrow adiposity in aged mice
por: Yu, Degang, et al.
Publicado: (2023) -
Loss of STAT1 in Bone Marrow-Derived Cells Accelerates Skeletal Muscle Regeneration
por: Gao, Yan, et al.
Publicado: (2012) -
Primary Hyperparathyroidism: The Influence of Bone Marrow Adipose Tissue on Bone Loss and of Osteocalcin on Insulin Resistance
por: Mendonça, Maira L., et al.
Publicado: (2016) -
Bone Marrow Adipose Tissue Deficiency Increases Disuse-Induced Bone Loss in Male Mice
por: Keune, Jessica A., et al.
Publicado: (2017) -
Contributions of Dickkopf‐1 to Obesity‐Induced Bone Loss and Marrow Adiposity
por: Colditz, Juliane, et al.
Publicado: (2020)